Advertisement

Topics

Artios licenses DNA damage repair program from Cancer Research Technology

15:40 EDT 22 Sep 2016 | Elsevier Business Intelligence

Cancer Research UK's Cancer Research Technology granted new oncology biotech Artios Pharma Ltd. rights to two targets in the field of DNA damage response (DDR).

Original Article: Artios licenses DNA damage repair program from Cancer Research Technology

NEXT ARTICLE

More From BioPortfolio on "Artios licenses DNA damage repair program from Cancer Research Technology"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...